CHI-MYST RESOLVE TOPICAL- chitosan ketorolac bupivacaine lidocaine suspension spray, metered

국가: 미국

언어: 영어

출처: NLM (National Library of Medicine)

유효 성분:

BUPIVACAINE HYDROCHLORIDE (UNII: 7TQO7W3VT8) (BUPIVACAINE - UNII:Y8335394RO), KETOROLAC TROMETHAMINE (UNII: 4EVE5946BQ) (KETOROLAC - UNII:YZI5105V0L), CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S) (UNII: SBD1A2I75N) (CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S) - UNII:SBD1A2I75N), LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)

제공처:

Prescription Care LLC

INN (International Name):

BUPIVACAINE HYDROCHLORIDE

구성:

BUPIVACAINE HYDROCHLORIDE ANHYDROUS 0.09 g in 30 mL

관리 경로:

TOPICAL

처방전 유형:

PRESCRIPTION DRUG

승인 상태:

unapproved drug other

제품 특성 요약

CHI-MYST RESOLVE TOPICAL- CHITOSAN KETOROLAC BUPIVACAINE LIDOCAINE
SUSPENSION SPRAY,
METERED
PRESCRIPTION CARE LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
CHI-MYST RESOLVE TOPICAL
DRUG INFORMATION
CHI-MYST RESOLVE TOPICAL
chitosan ketorolac bupivacaine lidocaine suspension spray, metered
Prescription Care LLC
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:70 48 6 -0 13
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
BUPIVACAINE HYDRO CHLO RIDE (UNII: 7TQO7W3VT8 ) (BUPIVACAINE -
UNII:Y8 33539 4RO)
BUPIVACAINE
HYDROCHLORIDE
ANHYDROUS
0 .0 9 g
in 30 mL
KETO RO LAC TRO METHAMINE (UNII: 4EVE59 46 BQ) (KETOROLAC -
UNII:YZI510 5V0 L)
KETOROLAC
0 .0 9 g
in 30 mL
CHITO SAN LO W MO LECULAR WEIGHT ( 2 0 -2 0 0 MPA.S) (UNII:
SBD1A2I75N)
(CHITOSAN LOW MOLECULAR WEIGHT (20 -20 0 MPA.S) - UNII:SBD1A2I75N)
CHITOSAN LOW MOLECULAR
WEIGHT (20 -20 0 MPA.S)
0 .0 3 g
in 30 mL
LIDO CAINE HYDRO CHLO RIDE (UNII: V130 0 7Z41A) (LIDOCAINE - UNII:9 8
PI20 0 9 8 7)
LIDOCAINE HYDROCHLORIDE
50 g
in 30 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
GLYCERIN (UNII: PDC6 A3C0 OX)
0 .3 mL in 30 mL
WATER (UNII: 0 59 QF0 KO0 R)
30 mL in 30 mL
LACTIC ACID LACTATE, DL- (UNII: N37QW3EK1L)
0 .0 42 mL in 30 mL
SO DIUM HYDRO XIDE (UNII: 55X0 4QC32I)
0 .0 135 g in 30 mL
PACKAG ING
# ITEM CODE
PACKAGE DESCRIPTION
MARKETING
START DATE
MARKETING
END DATE
1
NDC:70 48 6 -
0 13-30
30 mL in 1 BOTTLE, SPRAY; Type 9 : Other Type o f Part 3 Co mbinatio n
Pro duct
(e.g., Drug/Device/Bio lo gical Pro duct)
0 6 /0 1/20 16
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 6 /0 1/20 16
LABELER -
Prescription Care LLC (080059076)
REGISTRANT -
Prescription Care LLC (080059076)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSI